Attn, March 8, 2017. Pharmaceutical companies are exploiting a Food and Drug Administration (FDA) policy to undermine competitors and maintain monopolies on their products.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
2017 Foremother and Health Policy Hero Awards Luncheon Invitation
February 21, 2017. Reserve your ticket! We hope you will join us at our annual Awards Luncheon: Foremother and Health Policy Hero Awards. Monday May 15, 2017, at noon at the historic Mayflower Hotel. Champagne reception for patrons and sponsors at 11:30.
Read More »Amid Flurry of New Cancer Drugs, How Many Offer Real Benefits?
Kaiser Health News, February 9, 2017. For every cancer patient who wins the lottery, there are many others who get little to no benefit from the latest drugs.
Read More »Trump’s Proposed Changes Gut FDA While Targeting Drug Prices
Legal Reader, February 2, 2017. In a study published on the JAMA Network, Dr. Zuckerman and her co-author, Tracy Rupp, looked at certain new – and expensive – cancer drugs. They found that many of these drugs failed to improve patient quality of life or extend patient life.
Read More »Trump Calls for Lower Drug Prices, Fewer Regulations in Meeting with Pharmaceutical Executives
The Washington Post, January 31, 2017. President Trump met with leaders of some of the world’s biggest pharmaceutical companies Tuesday and emphasized the need to lower “astronomical” drug prices, decrease regulations and bring more drug manufacturing into the United States. “There are many empty positions at the FDA,” said Diana Zuckerman, president of the National Center for Health Research. The recently enacted 21st Century Cures law provided for additional hiring authority. “But with the hiring freeze, will they be able to hire anyone?” she asked.
Read More »